Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kensuke Oikawa

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|May 17, 2022
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicityYuki Yajima, Akemi Kosaka, Kei Ishibashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patientsToshihiro Nagato, Hiroya Kobayashi, Kan Kishibe, et al.
The American Journal of Pathology|March 26, 2003
Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig moleculesHitoshi Nochi, Naoko Aoki, Kensuke Oikawa, et al.
Pancreas|June 14, 2016
Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the PancreasSuguru Matsuzaka, Hidenori Karasaki, Yusuke Ono, et al.
BMC Gastroenterology|October 26, 2013
A therapeutic barium enema is a practical option to control bleeding from the appendixYoukou Konno, Mikihiro Fujiya, Kazuyuki Tanaka, et al.
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2020
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancerMizuho Ohara, Kenzo Ohara, Takumi Kumai, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatmentMarino Nagata, Akemi Kosaka, Yuki Yajima, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|May 17, 2022
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicityYuki Yajima, Akemi Kosaka, Kei Ishibashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patientsToshihiro Nagato, Hiroya Kobayashi, Kan Kishibe, et al.
The American Journal of Pathology|March 26, 2003
Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig moleculesHitoshi Nochi, Naoko Aoki, Kensuke Oikawa, et al.
Pancreas|June 14, 2016
Tracking the Clonal Evolution of Adenosquamous Carcinoma, a Rare Variant of Intraductal Papillary Mucinous Neoplasm of the PancreasSuguru Matsuzaka, Hidenori Karasaki, Yusuke Ono, et al.
BMC Gastroenterology|October 26, 2013
A therapeutic barium enema is a practical option to control bleeding from the appendixYoukou Konno, Mikihiro Fujiya, Kazuyuki Tanaka, et al.
Oncoimmunology|December 5, 2018
Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinomaKenzo Ohara, Takayuki Ohkuri, Takumi Kumai, et al.
Oncoimmunology|July 30, 2016
Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapyKei Ishibashi, Takumi Kumai, Takayuki Ohkuri, et al.
Cancer Immunology, Immunotherapy : CII|February 23, 2020
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancerMizuho Ohara, Kenzo Ohara, Takumi Kumai, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2021
A critical role of STING-triggered tumor-migrating neutrophils for anti-tumor effect of intratumoral cGAMP treatmentMarino Nagata, Akemi Kosaka, Yuki Yajima, et al.
Pageof 6